BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wong F, Nadim MK, Kellum JA, Salerno F, Bellomo R, Gerbes A, Angeli P, Moreau R, Davenport A, Jalan R, Ronco C, Genyk Y, Arroyo V. Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut. 2011;60:702-709. [PMID: 21325171 DOI: 10.1136/gut.2010.236133] [Cited by in Crossref: 256] [Cited by in F6Publishing: 220] [Article Influence: 25.6] [Reference Citation Analysis]
Number Citing Articles
1 Rognant N. Acute kidney injury in patients with chronic liver disease. World J Hepatol 2015; 7(7): 993-1000 [PMID: 25954481 DOI: 10.4254/wjh.v7.i7.993] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
2 Davies T, Wythe S, O'Beirne J, Martin D, Gilbert-Kawai E. Review article: the role of the microcirculation in liver cirrhosis. Aliment Pharmacol Ther 2017;46:825-35. [PMID: 29023881 DOI: 10.1111/apt.14279] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
3 Valerio C, Theocharidou E, Davenport A, Agarwal B. Human albumin solution for patients with cirrhosis and acute on chronic liver failure: Beyond simple volume expansion. World J Hepatol 2016; 8(7): 345-354 [PMID: 26981172 DOI: 10.4254/wjh.v8.i7.345] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 5.6] [Reference Citation Analysis]
4 Hasper D, Jörres A. New insights into the management of hepato-renal syndrome. Liver Int. 2011;31 Suppl 3:27-30. [PMID: 21824281 DOI: 10.1111/j.1478-3231.2011.02586.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
5 Saracyn M, Patera J, Kocik J, Brytan M, Zdanowski R, Lubas A, Kozłowski W, Wańkowicz Z. Strain of experimental animals and modulation of nitric oxide pathway: their influence on development of renal failure in an experimental model of hepatorenal syndrome. Arch Med Sci. 2012;8:555-562. [PMID: 22852015 DOI: 10.5114/aoms.2012.29281] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
6 Wi W, Hahm TS, Kim GS. A case series on simultaneous liver and kidney transplantation: do we need intraoperative renal replacement therapy? Korean J Anesthesiol 2017;70:467-76. [PMID: 28794844 DOI: 10.4097/kjae.2017.70.4.467] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
7 Kamimura H, Setsu T, Kimura N, Yokoo T, Sakamaki A, Kamimura K, Tsuchiya A, Takamura M, Yamagiwa S, Terai S. Renal Impairment in Chronic Hepatitis B: A Review. Diseases. 2018;6. [PMID: 29921773 DOI: 10.3390/diseases6020052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lake JR. Hot-topic debate on kidney function: Renal-sparing approaches are ineffective. Liver Transpl 2011;17:S50-3. [DOI: 10.1002/lt.22429] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Ojeda-Yuren AS, Cerda-Reyes E, Herrero-Maceda MR, Castro-Narro G, Piano S. An Integrated Review of the Hepatorenal Syndrome. Ann Hepatol 2021;22:100236. [PMID: 32846202 DOI: 10.1016/j.aohep.2020.07.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Angeli P, Gines P, Wong F, Bernardi M, Boyer TD, Gerbes A, Moreau R, Jalan R, Sarin SK, Piano S, Moore K, Lee SS, Durand F, Salerno F, Caraceni P, Kim WR, Arroyo V, Garcia-Tsao G; International Club of Ascites. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut. 2015;64:531-537. [PMID: 25631669 DOI: 10.1136/gutjnl-2014-308874] [Cited by in Crossref: 202] [Cited by in F6Publishing: 158] [Article Influence: 33.7] [Reference Citation Analysis]
11 Busk TM, Møller S, Pedersen EB, Gerbes A, Krag A, Peck-radosavljevic M, Frankova S, Coenraad MJ, Bendtsen F. Aquaporin-2 excretion in hospitalized patients with cirrhosis: Relation to development of renal insufficiency and mortality: Aquaporin-2 in cirrhotic patients. Journal of Gastroenterology and Hepatology 2017;32:1087-93. [DOI: 10.1111/jgh.13641] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
12 Kim SM, Song IH. [Acute Kidney Injury in Cirrhotic Patients with Portal Hypertension]. Korean J Gastroenterol 2016;68:237-44. [PMID: 27871159 DOI: 10.4166/kjg.2016.68.5.237] [Reference Citation Analysis]
13 Liu C, Huang C, Tsai H, Su Y, Huang S, Lee K, Hsieh Y, Li T, Tsai C, Chong L, Ou S, Yang Y, Fan W, Hou M, Lin H, Lee S. Serum adrenomedullin and urinary thromboxane B 2 help early categorizing of acute kidney injury in decompensated cirrhotic patients: A prospective cohort study. Hepatol Res 2018;48. [DOI: 10.1111/hepr.12917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Rajesh S, George T, Philips CA, Ahamed R, Kumbar S, Mohan N, Mohanan M, Augustine P. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update. World J Gastroenterol 2020; 26(37): 5561-5596 [PMID: 33088154 DOI: 10.3748/wjg.v26.i37.5561] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
15 Anand AC, Nandi B, Acharya SK, Arora A, Babu S, Batra Y, Chawla YK, Chowdhury A, Chaoudhuri A, Eapen EC, Devarbhavi H, Dhiman R, Datta Gupta S, Duseja A, Jothimani D, Kapoor D, Kar P, Khuroo MS, Kumar A, Madan K, Mallick B, Maiwall R, Mohan N, Nagral A, Nath P, Panigrahi SC, Pawar A, Philips CA, Prahraj D, Puri P, Rastogi A, Saraswat VA, Saigal S, Shalimar, Shukla A, Singh SP, Verghese T, Wadhawan M; INASL Task-Force on Acute Liver Failure. Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): Epidemiology, Pathogenesis, Presentation and Prognosis. J Clin Exp Hepatol 2020;10:339-76. [PMID: 32655238 DOI: 10.1016/j.jceh.2020.04.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
16 Jepsen P. Comorbidity in cirrhosis. World J Gastroenterol 2014; 20(23): 7223-7230 [PMID: 24966593 DOI: 10.3748/wjg.v20.i23.7223] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
17 Nadim MK, Sung RS, Davis CL, Andreoni KA, Biggins SW, Danovitch GM, Feng S, Friedewald JJ, Hong JC, Kellum JA, Kim WR, Lake JR, Melton LB, Pomfret EA, Saab S, Genyk YS. Simultaneous liver-kidney transplantation summit: current state and future directions. Am J Transplant. 2012;12:2901-2908. [PMID: 22822723 DOI: 10.1111/j.1600-6143.2012.04190.x] [Cited by in Crossref: 184] [Cited by in F6Publishing: 146] [Article Influence: 20.4] [Reference Citation Analysis]
18 Gomaa SH, Shamseya MM, Madkour MA. Clinical utility of urinary neutrophil gelatinase-associated lipocalin and serum cystatin C in a cohort of liver cirrhosis patients with renal dysfunction: a challenge in the diagnosis of hepatorenal syndrome.Eur J Gastroenterol Hepatol. 2019;31:692-702. [PMID: 30601335 DOI: 10.1097/MEG.0000000000001347] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Fagundes C, Pépin M, Guevara M, Barreto R, Casals G, Solà E, Pereira G, Rodríguez E, Garcia E, Prado V, Poch E, Jiménez W, Fernández J, Arroyo V, Ginès P. Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis. Journal of Hepatology 2012;57:267-73. [DOI: 10.1016/j.jhep.2012.03.015] [Cited by in Crossref: 129] [Cited by in F6Publishing: 102] [Article Influence: 14.3] [Reference Citation Analysis]
20 Kalambokis GN, Oikonomou A, Baltayiannis G, Christou L, Kolaitis NI, Tsianos EV. Thrombin generation measured as thrombin-antithrombin complexes predicts clinical outcomes in patients with cirrhosis. Hepatol Res. 2015;Epub ahead of print. [PMID: 25847196 DOI: 10.1111/hepr.12520] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
21 Piano S, Rosi S, Maresio G, Fasolato S, Cavallin M, Romano A, Morando F, Gola E, Frigo AC, Gatta A, Angeli P. Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites. J Hepatol. 2013;59:482-489. [PMID: 23665185 DOI: 10.1016/j.jhep.2013.03.039] [Cited by in Crossref: 151] [Cited by in F6Publishing: 122] [Article Influence: 18.9] [Reference Citation Analysis]
22 Moore JK, Love E, Craig DG, Hayes PC, Simpson KJ. Acute kidney injury in acute liver failure: a review. Expert Rev Gastroenterol Hepatol 2013;7:701-12. [PMID: 24134153 DOI: 10.1586/17474124.2013.837264] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
23 Jeon MY, Lee JS, Lee HW, Kim BK, Park JY, Kim DY, Han K, Ahn SH, Kim SU. Entecavir and tenofovir on renal function in patients with hepatitis B virus‐related hepatocellular carcinoma. J Viral Hepat 2020;27:932-40. [DOI: 10.1111/jvh.13313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Jiang W, Hu Y, Sun Y, Shen Y, Xun Y. Prevalence and short‐term outcome of acute kidney injury in patients with acute‐on‐chronic liver failure: A meta‐analysis. J Viral Hepat 2020;27:810-7. [DOI: 10.1111/jvh.13287] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
25 Belcher JM, Garcia-Tsao G, Sanyal AJ, Bhogal H, Lim JK, Ansari N, Coca SG, Parikh CR;  TRIBE-AKI Consortium. Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology. 2013;57:753-762. [PMID: 22454364 DOI: 10.1002/hep.25735] [Cited by in Crossref: 205] [Cited by in F6Publishing: 180] [Article Influence: 22.8] [Reference Citation Analysis]
26 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Liver transplantation. J Hepatol. 2016;64:433-485. [PMID: 26597456 DOI: 10.1016/j.jhep.2015.10.006] [Cited by in Crossref: 390] [Cited by in F6Publishing: 292] [Article Influence: 65.0] [Reference Citation Analysis]
27 Low G, Alexander GJ, Lomas DJ. Renal impairment in cirrhosis unrelated to hepatorenal syndrome. Can J Gastroenterol Hepatol 2015;29:253-7. [PMID: 25874649 DOI: 10.1155/2015/967683] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
28 Leithead JA, Hayes PC, Ferguson JW. Review article: advances in the management of patients with cirrhosis and portal hypertension-related renal dysfunction. Aliment Pharmacol Ther. 2014;39:699-711. [PMID: 24528130 DOI: 10.1111/apt.12653] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
29 Durand F, Graupera I, Ginès P, Olson JC, Nadim MK. Pathogenesis of Hepatorenal Syndrome: Implications for Therapy. Am J Kidney Dis 2016;67:318-28. [PMID: 26500178 DOI: 10.1053/j.ajkd.2015.09.013] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 8.5] [Reference Citation Analysis]
30 Martin P, DiMartini A, Feng S, Brown R, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology. 2014;59:1144-1165. [PMID: 24716201 DOI: 10.1002/hep.26972] [Cited by in Crossref: 429] [Cited by in F6Publishing: 322] [Article Influence: 61.3] [Reference Citation Analysis]
31 Amin AA, Alabsawy EI, Jalan R, Davenport A. Epidemiology, Pathophysiology, and Management of Hepatorenal Syndrome. Seminars in Nephrology 2019;39:17-30. [DOI: 10.1016/j.semnephrol.2018.10.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
32 Mindikoglu AL, Dowling TC, Wong-You-Cheong JJ, Christenson RH, Magder LS, Hutson WR, Seliger SL, Weir MR. A pilot study to evaluate renal hemodynamics in cirrhosis by simultaneous glomerular filtration rate, renal plasma flow, renal resistive indices and biomarkers measurements. Am J Nephrol. 2014;39:543-552. [PMID: 24943131 DOI: 10.1159/000363584] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
33 Weber ML, Ibrahim HN, Lake JR. Renal dysfunction in liver transplant recipients: evaluation of the critical issues. Liver Transpl. 2012;18:1290-1301. [PMID: 22847917 DOI: 10.1002/lt.23522] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 6.9] [Reference Citation Analysis]
34 Karvellas CJ, Durand F, Nadim MK. Acute Kidney Injury in Cirrhosis. Critical Care Clinics 2015;31:737-50. [DOI: 10.1016/j.ccc.2015.06.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
35 Iglesias J, Frank E, Mehandru S, Davis JM, Levine JS. Predictors of renal recovery in patients with pre-orthotopic liver transplant (OLT) renal dysfunction. BMC Nephrol 2013;14:147. [PMID: 23849513 DOI: 10.1186/1471-2369-14-147] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
36 O'Leary JG, Levitsky J, Wong F, Nadim MK, Charlton M, Kim WR. Protecting the Kidney in Liver Transplant Candidates: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice. Am J Transplant 2016;16:2516-31. [PMID: 26990924 DOI: 10.1111/ajt.13790] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
37 Garcia-Martinez R, Noiret L, Sen S, Mookerjee R, Jalan R. Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury. Liver Int. 2015;35:335-343. [PMID: 24620819 DOI: 10.1111/liv.12528] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
38 Peng JC, Li YJ, Wang J-, Zhu ML, Gao Y. Incidence of chronic kidney disease after orthotopic liver transplantation in a Chinese cohort. Clin Exp Nephrol 2020;24:806-12. [PMID: 32504202 DOI: 10.1007/s10157-020-01910-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Eknoyan G, Epstein M. Hepatorenal syndrome: a historical appraisal of its origins and conceptual evolution. Kidney Int 2021;99:1321-30. [PMID: 33781792 DOI: 10.1016/j.kint.2021.02.037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Reuken PA, Stallmach A, Bruns T. Mortality after urinary tract infections in patients with advanced cirrhosis - Relevance of acute kidney injury and comorbidities. Liver Int. 2013;33:220-230. [PMID: 23295053 DOI: 10.1111/liv.12029] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
41 Huschak G, Kaisers U, Laudi S. Hepatorenales Syndrom. Anaesthesist 2013;62:571-82. [DOI: 10.1007/s00101-013-2197-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
42 Huelin P, Piano S, Solà E, Stanco M, Solé C, Moreira R, Pose E, Fasolato S, Fabrellas N, de Prada G, Pilutti C, Graupera I, Ariza X, Romano A, Elia C, Cárdenas A, Fernández J, Angeli P, Ginès P. Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute-on-Chronic Liver Failure. Clin Gastroenterol Hepatol 2017;15:438-445.e5. [PMID: 27720915 DOI: 10.1016/j.cgh.2016.09.156] [Cited by in F6Publishing: 50] [Reference Citation Analysis]
43 Shah N, Dhar D, El Zahraa Mohammed F, Habtesion A, Davies NA, Jover-Cobos M, Macnaughtan J, Sharma V, Olde Damink SW, Mookerjee RP, Jalan R. Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression. J Hepatol. 2012;56:1047-1053. [PMID: 22266601 DOI: 10.1016/j.jhep.2011.11.024] [Cited by in Crossref: 80] [Cited by in F6Publishing: 67] [Article Influence: 8.9] [Reference Citation Analysis]
44 European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406-460. [PMID: 29653741 DOI: 10.1016/j.jhep.2018.03.024] [Cited by in Crossref: 660] [Cited by in F6Publishing: 520] [Article Influence: 220.0] [Reference Citation Analysis]
45 Loo NM, Souza FF, Garcia-Tsao G. Non-hemorrhagic acute complications associated with cirrhosis and portal hypertension. Best Pract Res Clin Gastroenterol 2013;27:665-78. [PMID: 24160926 DOI: 10.1016/j.bpg.2013.08.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
46 Nadim MK, Durand F, Kellum JA, Levitsky J, O’leary JG, Karvellas CJ, Bajaj JS, Davenport A, Jalan R, Angeli P, Caldwell SH, Fernández J, Francoz C, Garcia-tsao G, Ginès P, Ison MG, Kramer DJ, Mehta RL, Moreau R, Mulligan D, Olson JC, Pomfret EA, Senzolo M, Steadman RH, Subramanian RM, Vincent J, Genyk YS. Management of the critically ill patient with cirrhosis: A multidisciplinary perspective. Journal of Hepatology 2016;64:717-35. [DOI: 10.1016/j.jhep.2015.10.019] [Cited by in Crossref: 150] [Cited by in F6Publishing: 111] [Article Influence: 30.0] [Reference Citation Analysis]
47 Ra G, Tsien C, Renner EL, Wong FS. The Negative Prognostic Impact of a First Ever Episode of Spontaneous Bacterial Peritonitis in Cirrhosis and Ascites. Journal of Clinical Gastroenterology 2015;49:858-65. [DOI: 10.1097/mcg.0000000000000311] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
48 Leithead JA, Armstrong MJ, Corbett C, Andrew M, Kothari C, Gunson BK, Mirza D, Muiesan P, Ferguson JW. Split liver transplant recipients do not have an increased frequency of acute kidney injury. Transpl Int 2014;27:1125-34. [DOI: 10.1111/tri.12376] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
49 Davenport A, Sheikh MF, Lamb E, Agarwal B, Jalan R. Acute kidney injury in acute-on-chronic liver failure: where does hepatorenal syndrome fit? Kidney Int. 2017;92:1058-1070. [PMID: 28844314 DOI: 10.1016/j.kint.2017.04.048] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 9.8] [Reference Citation Analysis]
50 Parke CY, Martin P, Bunnapradist S. Renal dysfunction in cirrhosis. Clin Liver Dis (Hoboken). 2015;5:150-153. [PMID: 31040973 DOI: 10.1002/cld.485] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
51 Nuthalapati A, Schluterman N, Khanna A, Greenberg D, Thuluvath PJ. Impact of Acute Kidney Injury on Mortality of Patients Hospitalized for Complications of Cirrhosis. J Clin Exp Hepatol 2017;7:290-9. [PMID: 29234192 DOI: 10.1016/j.jceh.2017.05.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
52 Ruebner R, Goldberg D, Abt PL, Bahirwani R, Levine M, Sawinski D, Bloom RD, Reese PP. Risk of end-stage renal disease among liver transplant recipients with pretransplant renal dysfunction. Am J Transplant. 2012;12:2958-2965. [PMID: 22759237 DOI: 10.1111/j.1600-6143.2012.04177.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 7.9] [Reference Citation Analysis]
53 Sersté T, Njimi H, Degré D, Deltenre P, Schreiber J, Lepida A, Trépo E, Gustot T, Moreno C. The use of beta-blockers is associated with the occurrence of acute kidney injury in severe alcoholic hepatitis. Liver Int. 2015;35:1974-1982. [PMID: 25611961 DOI: 10.1111/liv.12786] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
54 Baraldi O, Valentini C, Donati G, Comai G, Cuna V, Capelli I, Angelini ML, Moretti MI, Angeletti A, Piscaglia F, Manna GL. Hepatorenal syndrome: Update on diagnosis and treatment. World J Nephrol 2015; 4(5): 511-520 [PMID: 26558188 DOI: 10.5527/wjn.v4.i5.511] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
55 Mindikoglu AL, Weir MR. Current concepts in the diagnosis and classification of renal dysfunction in cirrhosis. Am J Nephrol. 2013;38:345-354. [PMID: 24107793 DOI: 10.1159/000355540] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
56 Wu HC, Lee LC, Wang WJ. Incidence and mortality of postoperative acute kidney injury in non-dialysis patients: comparison between the AKIN and KDIGO criteria. Ren Fail 2016;38:330-9. [PMID: 26768125 DOI: 10.3109/0886022X.2015.1128790] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
57 Maiwall R, Sarin SK, Moreau R. Acute kidney injury in acute on chronic liver failure. Hepatol Int 2016;10:245-57. [DOI: 10.1007/s12072-015-9652-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
58 Solé C, Pose E, Solà E, Ginès P. Hepatorenal syndrome in the era of acute kidney injury.Liver Int. 2018;38:1891-1901. [PMID: 29845739 DOI: 10.1111/liv.13893] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 7.7] [Reference Citation Analysis]
59 Al-khafaji A, Nadim MK, Kellum JA. Hepatorenal Disorders. Chest 2015;148:550-8. [DOI: 10.1378/chest.14-1925] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
60 Adebayo D, Neong SF, Wong F. Ascites and Hepatorenal Syndrome. Clin Liver Dis 2019;23:659-82. [PMID: 31563217 DOI: 10.1016/j.cld.2019.06.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
61 O'Leary JG, Wong F, Reddy KR, Garcia-Tsao G, Kamath PS, Biggins SW, Fallon MB, Subramanian RM, Maliakkal B, Thacker L, Bajaj JS. Gender-Specific Differences in Baseline, Peak, and Delta Serum Creatinine: The NACSELD Experience. Dig Dis Sci. 2017;62:768-776. [PMID: 28025746 DOI: 10.1007/s10620-016-4416-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
62 Arase Y, Kagawa T, Tsuruya K, Sato H, Teramura E, Anzai K, Hirose S, Deguchi R, Shiraishi K, Mine T. Impaired Renal Function May Not Negate the Efficacy of Tolvaptan in the Treatment of Cirrhotic Patients with Refractory Ascites. Clin Drug Investig 2019;39:45-54. [PMID: 30284699 DOI: 10.1007/s40261-018-0714-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
63 Møller S, Bendtsen F. Cirrhotic Multiorgan Syndrome. Dig Dis Sci 2015;60:3209-25. [DOI: 10.1007/s10620-015-3752-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
64 Rodriguez E, Henrique Pereira G, Solà E, Elia C, Barreto R, Pose E, Colmenero J, Fernandez J, Navasa M, Arroyo V. Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: Effects on kidney function and transplantation outcomes. Liver Transpl. 2015;21:1347-1354. [PMID: 26178066 DOI: 10.1002/lt.24210] [Cited by in Crossref: 40] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
65 Busk TM, Bendtsen F, Møller S. Hepatorenal syndrome in cirrhosis: diagnostic, pathophysiological, and therapeutic aspects.Expert Rev Gastroenterol Hepatol. 2016;10:1153-1161. [PMID: 27248461 DOI: 10.1080/17474124.2016.1196132] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
66 Angeli P, Sanyal A, Moller S, Alessandria C, Gadano A, Kim R, Sarin SK, Bernardi M; International Club of Ascites. Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites. Liver Int 2013;33:16-23. [PMID: 22507181 DOI: 10.1111/j.1478-3231.2012.02807.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 5.2] [Reference Citation Analysis]
67 Rey R M, Delgado AF, De Zubiria A, Pinto R, De la Hoz-Valle JA, Pérez-Riveros ED, Ardila G, Sierra-Arango F. Prevalence and short-term outcome of hepatorenal syndrome: A 9-year experience in a high-complexity hospital in Colombia. PLoS One 2020;15:e0239834. [PMID: 33079947 DOI: 10.1371/journal.pone.0239834] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
68 Papaluca T, Gow P. Terlipressin: Current and emerging indications in chronic liver disease: Current and emerging indications. Journal of Gastroenterology and Hepatology 2018;33:591-8. [DOI: 10.1111/jgh.14009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
69 Wong F, Murray P. Kidney damage biomarkers: Novel tools for the diagnostic assessment of acute kidney injury in cirrhosis. Hepatology 2014;60:455-7. [PMID: 24700173 DOI: 10.1002/hep.27063] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
70 Cardenas A. Defining renal failure in cirrhosis -Acute kidney injury classification or traditional criteria? Annals of Hepatology 2013;12:984-5. [DOI: 10.1016/s1665-2681(19)31307-9] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
71 Wong F, Leung W, Al Beshir M, Marquez M, Renner EL. Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation: HRS1 AND LIVER TRANSPLANTATION. Liver Transpl 2015;21:300-7. [DOI: 10.1002/lt.24049] [Cited by in Crossref: 72] [Cited by in F6Publishing: 56] [Article Influence: 12.0] [Reference Citation Analysis]
72 Berg T, Zoulim F, Moeller B, Trinh H, Marcellin P, Chan S, Kitrinos KM, Dinh P, Flaherty JF Jr, McHutchison JG, Manns M. Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients. J Hepatol. 2014;60:715-722. [PMID: 24295873 DOI: 10.1016/j.jhep.2013.11.024] [Cited by in Crossref: 64] [Cited by in F6Publishing: 60] [Article Influence: 8.0] [Reference Citation Analysis]
73 Umbro I, Tinti F, Scalera I, Evison F, Gunson B, Sharif A, Ferguson J, Muiesan P, Mitterhofer AP. Acute kidney injury and post-reperfusion syndrome in liver transplantation. World J Gastroenterol 2016; 22(42): 9314-9323 [PMID: 27895419 DOI: 10.3748/wjg.v22.i42.9314] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
74 MacDonald AJ, Nadim MK, Durand F, Karvellas CJ. Acute kidney injury in cirrhosis: implications for liver transplantation. Curr Opin Crit Care. 2019;25:171-178. [PMID: 30676329 DOI: 10.1097/mcc.0000000000000590] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
75 Chancharoenthana W, Leelahavanichkul A. Acute kidney injury spectrum in patients with chronic liver disease: Where do we stand? World J Gastroenterol 2019; 25(28): 3684-3703 [PMID: 31391766 DOI: 10.3748/wjg.v25.i28.3684] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
76 Asrani SK, O'Leary JG. Acute-on-chronic liver failure. Clin Liver Dis. 2014;18:561-574. [PMID: 25017076 DOI: 10.1016/j.cld.2014.05.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
77 Møller S, Henriksen JH, Bendtsen F. Extrahepatic complications to cirrhosis and portal hypertension: Haemodynamic and homeostatic aspects. World J Gastroenterol 2014; 20(42): 15499-15517 [PMID: 25400435 DOI: 10.3748/wjg.v20.i42.15499] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
78 Kitamura M, Hidaka M, Muta K, Miuma S, Miyaaki H, Takatsuki M, Nakao K, Eguchi S, Mukae H, Nishino T. Prediction of Liver Prognosis from Pre-Transplant Renal Function Adjusted by Diuretics and Urinary Abnormalities in Adult-to-Adult Living Donor Liver Transplantation. Ann Transplant 2020;25:e924805. [PMID: 32895363 DOI: 10.12659/AOT.924805] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Erly B, Carey WD, Kapoor B, McKinney JM, Tam M, Wang W. Hepatorenal Syndrome: A Review of Pathophysiology and Current Treatment Options. Semin Intervent Radiol. 2015;32:445-454. [PMID: 26622108 DOI: 10.1055/s-0035-1564794] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
80 Piano S, Tonon M, Cavallin M, Morando F, Romano A, Gola E, Fasolato S, Angeli P. Reply to: "A cut-off serum creatinine value of 1.5 mg/dl for AKI--to be or not to be". J Hepatol 2015;62:744-6. [PMID: 25485796 DOI: 10.1016/j.jhep.2014.12.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
81 Leithead JA, Ferguson JW, Bates CM, Davidson JS, Simpson KJ, Hayes PC. Chronic Kidney Disease After Liver Transplantation for Acute Liver Failure Is Not Associated With Perioperative Renal Dysfunction: Acute Liver Failure: Posttransplant Renal Function. American Journal of Transplantation 2011;11:1905-15. [DOI: 10.1111/j.1600-6143.2011.03649.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
82 Sampaio MS, Martin P, Bunnapradist S. Renal dysfunction in end-stage liver disease and post-liver transplant. Clin Liver Dis 2014;18:543-60. [PMID: 25017075 DOI: 10.1016/j.cld.2014.05.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
83 Hilmi IA, Damian D, Al-Khafaji A, Sakai T, Donaldson J, Winger DG, Kellum JA. Acute kidney injury after orthotopic liver transplantation using living donor versus deceased donor grafts: A propensity score-matched analysis. Liver Transpl 2015;21:1179-85. [PMID: 25980614 DOI: 10.1002/lt.24166] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
84 Urrunaga NH, Mindikoglu AL, Rockey DC. Renal dysfunction in cirrhosis. Curr Opin Gastroenterol 2015;31:215-23. [PMID: 25763790 DOI: 10.1097/MOG.0000000000000168] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
85 Jindal A, Kumar M, Bhadoria AS, Maiwall R, Sarin SK. A randomized open label study of ‘imipenem vs. cefepime’ in spontaneous bacterial peritonitis. Liver Int. 2016;36:677-687. [PMID: 26474358 DOI: 10.1111/liv.12985] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
86 Zhang J, Gao S, Duan Z, Hu KQ. Overview on acute-on-chronic liver failure. Front Med 2016;10:1-17. [PMID: 26976617 DOI: 10.1007/s11684-016-0439-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
87 Li H, Fan MQ, Men TY, Wang YP, Xing TH, Fan JW, Peng ZH, Zhong L. Long-Term Outcomes of Simultaneous Liver-Kidney Transplant Patients with Hepatitis B Compared to with Liver Transplant Alone. Med Sci Monit 2016;22:332-40. [PMID: 26828767 DOI: 10.12659/MSM.895757] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
88 Bucsics T, Mandorfer M, Schwabl P, Bota S, Sieghart W, Ferlitsch A, Trauner M, Peck-Radosavljevic M, Reiberger T. Impact of acute kidney injury on prognosis of patients with liver cirrhosis and ascites: A retrospective cohort study. J Gastroenterol Hepatol. 2015;30:1657-1665. [PMID: 25967931 DOI: 10.1111/jgh.13002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
89 Nevens F, Pirenne J. Renal disease in the allograft recipient. Best Pract Res Clin Gastroenterol 2020;46-47:101690. [PMID: 33158468 DOI: 10.1016/j.bpg.2020.101690] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
90 Angeli P, Garcia-Tsao G, Nadim MK, Parikh CR. News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document. J Hepatol. 2019;71:811-822. [PMID: 31302175 DOI: 10.1016/j.jhep.2019.07.002] [Cited by in Crossref: 77] [Cited by in F6Publishing: 61] [Article Influence: 38.5] [Reference Citation Analysis]
91 Scott RA, Austin AS, Kolhe NV, McIntyre CW, Selby NM. Acute kidney injury is independently associated with death in patients with cirrhosis. Frontline Gastroenterol 2013;4:191-7. [PMID: 24660054 DOI: 10.1136/flgastro-2012-100291] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
92 Muciño-bermejo J, Carrillo-esper R, Uribe M, Méndez-sánchez N. Acute kidney injury in critically ill cirrhotic patients: a review. Annals of Hepatology 2012;11:301-10. [DOI: 10.1016/s1665-2681(19)30924-x] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
93 Davenport A, Agarwal B, Wright G, Mantzoukis K, Dimitrova R, Davar J, Vasianopoulou P, Burroughs AK. Can non-invasive measurements aid clinical assessment of volume in patients with cirrhosis? World J Hepatol 2013; 5(8): 433-438 [PMID: 24023982 DOI: 10.4254/wjh.v5.i8.433] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
94 Umbro I, Rossi M, Tinti F, Fiacco F, Piselli P, Ianni S, Ginanni Corradini S, Poli L, Berloco P, Mitterhofer A. Stages of Early Acute Renal Dysfunction in Liver Transplantation: The Influence of Graft Function. Transplantation Proceedings 2012;44:1953-5. [DOI: 10.1016/j.transproceed.2012.06.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
95 Vorobioff JD, Contreras F, Tanno F, Hernández L, Bessone F, Colombato L, Adi J, Fassio E, Felgueres M, Fernández G, Gaite L, Gibelli D, Darrichon HG, Lafage M, Lombardo D, López S, Mateo A, Mendizábal M, Pecoraro J, Ruf A, Ruiz P, Severini J, Stieben T, Sixto M, Zárate F, Barraza SB, Sierra ID, Pacheco VR, Roblero JP, Rojas JO, González PR, Rodríguez DSM, Sierralta A, Manchego AU, Valdes E, Yaquich P, Wolff R, Valdivia FB, Gallegos RC, Galloso R, Marcelo JS, Montes P, Tenorio L, Veramendi I, Alava E, Armijos X, Benalcazar G, Carrera E, Pazmiño GF, Díaz EM, Garassini M, Marrero RP, Infante M, Suárez DP, Gutiérrez JC, Reyes CMV, Serrano YM, Hernández RH, Martínez OM, González TP, Andara MT, Hernández MS, Gerona S, García I, Tijera F, López EP, Torres K, Garzón M. A Latin American survey on demographic aspects of hospitalized, decompensated cirrhotic patients and the resources for their management. Ann Hepatol 2020;19:396-403. [PMID: 32418749 DOI: 10.1016/j.aohep.2020.03.007] [Reference Citation Analysis]
96 Hunyady B, Jaroszewicz J, Lipták Ľ, Skladaný Ľ, Sperl J, Šváč J. Hepatology topics of special interest from Central Europe (Czech Republic, Hungary, Poland, Slovakia). Clin Exp Hepatol 2016;2:16-20. [PMID: 28856267 DOI: 10.5114/ceh.2016.58852] [Reference Citation Analysis]
97 Scherer JS, Holley JL. The Role of Time-Limited Trials in Dialysis Decision Making in Critically Ill Patients. Clin J Am Soc Nephrol 2016;11:344-53. [PMID: 26450932 DOI: 10.2215/CJN.03550315] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
98 Reiberger T, Püspök A, Schoder M, Baumann-Durchschein F, Bucsics T, Datz C, Dolak W, Ferlitsch A, Finkenstedt A, Graziadei I, Hametner S, Karnel F, Krones E, Maieron A, Mandorfer M, Peck-Radosavljevic M, Rainer F, Schwabl P, Stadlbauer V, Stauber R, Tilg H, Trauner M, Zoller H, Schöfl R, Fickert P. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III). Wien Klin Wochenschr 2017;129:135-58. [PMID: 29063233 DOI: 10.1007/s00508-017-1262-3] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 15.5] [Reference Citation Analysis]
99 Belcher JM, Sanyal AJ, Garcia-Tsao G, Ansari N, Coca SG, Shlipak MG, Parikh CR. Early trends in cystatin C and outcomes in patients with cirrhosis and acute kidney injury. Int J Nephrol 2014;2014:708585. [PMID: 24757564 DOI: 10.1155/2014/708585] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
100 Angeli P, Piano S. Is type 2 hepatorenal syndrome still a potential indication for treatment with terlipressin and albumin? Liver Transpl 2015;21:1335-7. [PMID: 26369385 DOI: 10.1002/lt.24339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
101 Salerno F, Cazzaniga M, Merli M, Spinzi G, Saibeni S, Salmi A, Fagiuoli S, Spadaccini A, Trotta E, Laffi G, Koch M, Riggio O, Boccia S, Felder M, Balzani S, Bruno S, Angeli P;  Italian Association of the Hospital Gastroenterologists (AIGO) investigators. Diagnosis, treatment and survival of patients with hepatorenal syndrome: a survey on daily medical practice. J Hepatol. 2011;55:1241-1248. [PMID: 21703199 DOI: 10.1016/j.jhep.2011.03.012] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 5.8] [Reference Citation Analysis]
102 Kim SG, Larson JJ, Lee JS, Therneau TM, Kim WR. Beneficial and harmful effects of nonselective beta blockade on acute kidney injury in liver transplant candidates. Liver Transpl. 2017;23:733-740. [PMID: 28187503 DOI: 10.1002/lt.24744] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
103 O'leary JG, Orloff SL, Levitsky J, Martin P, Foley DP. Keeping high model for end-stage liver disease score liver transplantation candidates alive: KEEPING LT CANDIDATES ALIVE. Liver Transpl 2015;21:1428-37. [DOI: 10.1002/lt.24329] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
104 Alferink LJM, Oey RC, Hansen BE, Polak WG, van Buuren HR, de Man RA, Schurink CAM, Metselaar HJ. The impact of infections on delisting patients from the liver transplantation waiting list. Transpl Int 2017;30:807-16. [PMID: 28403563 DOI: 10.1111/tri.12965] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
105 Xiong J, Pu L, Xiong H, Xiang P, Zhang M, Liu J, Li A. Evaluation of the criteria of hepatorenal syndrome type of acute kidney injury in patients with cirrhosis admitted to ICU. Scand J Gastroenterol 2018;53:1590-6. [PMID: 30621473 DOI: 10.1080/00365521.2018.1545423] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
106 Lerschmacher O, Koch A, Streetz K, Trautwein C, Tacke F. [Management of decompensated liver cirrhosis in the intensive care unit]. Med Klin Intensivmed Notfmed. 2013;108:646-656. [PMID: 24030843 DOI: 10.1007/s00063-013-0259-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
107 Fuhrmann V, Horvatits T, Drolz A, Rutter K. Extrakorporale Therapien bei Patienten mit Lebererkrankungen auf der Intensivstation. Med Klin Intensivmed Notfmed 2014;109:246-51. [DOI: 10.1007/s00063-013-0321-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
108 Belcher JM, Parikh CR, Garcia-Tsao G. Acute kidney injury in patients with cirrhosis: perils and promise. Clin Gastroenterol Hepatol. 2013;11:1550-1558. [PMID: 23583467 DOI: 10.1016/j.cgh.2013.03.018] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 4.5] [Reference Citation Analysis]
109 Umbro I, Tinti F, Fiacco F, Zavatto A, Piselli P, Di Natale V, Lai S, Vitarelli A, Corradini SG, Rossi M. Resistive index and MELD-Na: nephrologic monitoring in cirrhotic patients awaiting liver transplantation. Transplant Proc. 2013;45:2676-2679. [PMID: 24034022 DOI: 10.1016/j.transproceed.2013.07.040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
110 Colle I, Laterre PF. Hepatorenal syndrome: the clinical impact of vasoactive therapy. Expert Rev Gastroenterol Hepatol. 2018;12:173-188. [PMID: 29258378 DOI: 10.1080/17474124.2018.1417034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
111 Niewiński G, Smyk W, Graczyńska A, Kostrzewa K, Raszeja-Wyszomirska J, Ołdakowska-Jedynak U, Małyszko J, Wójcicki M, Zieniewicz K. Kidney Function After Liver Transplantation in a Single Center. Ann Transplant 2021;26:e926928. [PMID: 33619240 DOI: 10.12659/AOT.926928] [Reference Citation Analysis]
112 Umbro I, Tinti F, Fiacco F, Zavatto A, Di Natale V, Ginanni Corradini S, Rossi M, Poli L, Berloco PB, Mitterhofer AP. From listing to transplant: nephrologic monitoring in cirrhotic patients awaiting liver transplantation. Transplant Proc 2013;45:2672-5. [PMID: 24034021 DOI: 10.1016/j.transproceed.2013.07.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
113 Patidar KR, Kang L, Bajaj JS, Carl D, Sanyal AJ. Fractional excretion of urea: A simple tool for the differential diagnosis of acute kidney injury in cirrhosis. Hepatology. 2018;68:224-233. [PMID: 29315697 DOI: 10.1002/hep.29772] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
114 Umbro I, Tinti F, Piselli P, Fiacco F, Giannelli V, Di Natale V, Zavatto A, Merli M, Rossi M, Ginanni Corradini S, Poli L, Berloco P, Mitterhofer A. Occurrence of Chronic Renal Failure in Liver Transplantation: Monitoring of Pre- and Posttransplantation Renal Function. Transplantation Proceedings 2012;44:1956-9. [DOI: 10.1016/j.transproceed.2012.06.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
115 Kandil MA, Abouelenain KM, Alsebaey A, Rashed HS, Afifi MH, Mahmoud MA, Yassen KA. Impact of terlipressin infusion during and after live donor liver transplantation on incidence of acute kidney injury and neutrophil gelatinase-associated lipocalin serum levels: A randomized controlled trial. Clin Transplant 2017;31. [PMID: 28564127 DOI: 10.1111/ctr.13019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
116 Bunchorntavakul C, Chamroonkul N, Chavalitdhamrong D. Bacterial infections in cirrhosis: A critical review and practical guidance. World J Hepatol 2016; 8(6): 307-321 [PMID: 26962397 DOI: 10.4254/wjh.v8.i6.307] [Cited by in Crossref: 97] [Cited by in F6Publishing: 81] [Article Influence: 19.4] [Reference Citation Analysis]
117 Fong TL, Khemichian S, Shah T, Hutchinson IV, Cho YW. Combined liver-kidney transplantation is preferable to liver transplant alone for cirrhotic patients with renal failure. Transplantation. 2012;94:411-416. [PMID: 22805440 DOI: 10.1097/tp.0b013e3182590d6b] [Cited by in Crossref: 77] [Cited by in F6Publishing: 28] [Article Influence: 8.6] [Reference Citation Analysis]
118 Saracyn M, Zdanowski R, Brytan M, Kade G, Nowak Z, Patera J, Dyrla P, Gil J, Wańkowicz Z. D-Galactosamine Intoxication in Experimental Animals: Is it Only an Experimental Model of Acute Liver Failure? Med Sci Monit 2015;21:1469-77. [PMID: 26009004 DOI: 10.12659/MSM.893291] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
119 Hsu WF, Yu SH, Lin JT, Wu JC, Hou MC, Huang YH, Wu CY, Peng CY. Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study. Gastroenterol Res Pract 2019;2019:1743290. [PMID: 31687012 DOI: 10.1155/2019/1743290] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
120 Carl DE, Ghosh SS, Gehr TW, Abbate A, Toldo S, Sanyal AJ. A model of acute kidney injury in mice with cirrhosis and infection. Liver Int 2016;36:865-73. [PMID: 26583566 DOI: 10.1111/liv.13023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
121 de Carvalho JR, Villela-Nogueira CA, Luiz RR, Guzzo PL, da Silva Rosa JM, Rocha E, Moraes Coelho HS, de Mello Perez R. Acute kidney injury network criteria as a predictor of hospital mortality in cirrhotic patients with ascites. J Clin Gastroenterol. 2012;46:e21-e26. [PMID: 21934526 DOI: 10.1097/mcg.0b013e31822e8e12] [Cited by in Crossref: 68] [Cited by in F6Publishing: 25] [Article Influence: 7.6] [Reference Citation Analysis]
122 Battula N, Reichman TW, Amiri Y, Carmody IC, Galliano G, Seal J, Bugeaud E, Bohorquez H, Bruce D, Cohen A, Loss GE. Outcomes utilizing imported liver grafts for recipients with hepatocellular carcinoma. Liver Transpl 2017;23:299-304. [PMID: 28026108 DOI: 10.1002/lt.24709] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
123 Russ KB, Stevens TM, Singal AK. Acute Kidney Injury in Patients with Cirrhosis. J Clin Transl Hepatol. 2015;3:195-204. [PMID: 26623266 DOI: 10.14218/jcth.2015.00015] [Cited by in Crossref: 43] [Cited by in F6Publishing: 14] [Article Influence: 7.2] [Reference Citation Analysis]
124 Lenz K, Buder R, Kapun L, Voglmayr M. Treatment and management of ascites and hepatorenal syndrome: an update. Therap Adv Gastroenterol 2015;8:83-100. [PMID: 25729433 DOI: 10.1177/1756283X14564673] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
125 Stratmann K, Fitting D, Zeuzem S, Bojunga J, Trebicka J, Friedrich-Rust M, Dultz G. Establishing an indwelling peritoneal catheter as a standard procedure for hospitalized patients with ascites: Retrospective data on feasibility, effectiveness and safety. United European Gastroenterol J 2019;7:673-81. [PMID: 31210945 DOI: 10.1177/2050640619842442] [Reference Citation Analysis]
126 Gungor G, Ataseven H, Demir A, Solak Y, Gaipov A, Biyik M, Ozturk B, Polat I, Kiyici A, Cakir OO. Neutrophil gelatinase-associated lipocalin in prediction of mortality in patients with hepatorenal syndrome: a prospective observational study. Liver Int. 2014;34:49-57. [PMID: 23799980 DOI: 10.1111/liv.12232] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
127 Bajaj JS, O'Leary JG, Wong F, Reddy KR, Kamath PS. Bacterial infections in end-stage liver disease: current challenges and future directions. Gut. 2012;61:1219-1225. [PMID: 22661495 DOI: 10.1136/gutjnl-2012-302339] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 6.1] [Reference Citation Analysis]
128 Jindal A, Bhadoria AS, Maiwall R, Sarin SK. Evaluation of acute kidney injury and its response to terlipressin in patients with acute-on-chronic liver failure. Liver Int 2016;36:59-67. [DOI: 10.1111/liv.12895] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
129 Egerod Israelsen M, Gluud LL, Krag A. Acute kidney injury and hepatorenal syndrome in cirrhosis. J Gastroenterol Hepatol 2015;30:236-43. [PMID: 25160511 DOI: 10.1111/jgh.12709] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
130 Chen HP, Tsai YF, Lin JR, Liu FC, Yu HP. Incidence and Outcomes of Acute Renal Failure Following Liver Transplantation: A Population-Based Cohort Study. Medicine (Baltimore) 2015;94:e2320. [PMID: 26717368 DOI: 10.1097/MD.0000000000002320] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
131 Risør LM, Bendtsen F, Møller S. Immunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction. Hepatol Int 2015;9:17-27. [DOI: 10.1007/s12072-014-9581-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
132 Jagarlamudi N, Wong F. Acute kidney injury: prediction, prognostication and optimisation for liver transplant. Hepatol Int 2020;14:167-79. [DOI: 10.1007/s12072-020-10018-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
133 Caragata R, Wyssusek KH, Kruger P. Acute kidney injury following liver transplantation: a systematic review of published predictive models. Anaesth Intensive Care 2016;44:251-61. [PMID: 27029658 DOI: 10.1177/0310057X1604400212] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 3.6] [Reference Citation Analysis]
134 Wong F. The evolving concept of acute kidney injury in patients with cirrhosis. Nat Rev Gastroenterol Hepatol. 2015;12:711-719. [PMID: 26484442 DOI: 10.1038/nrgastro.2015.174] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
135 Dundar HZ, Yılmazlar T. Management of hepatorenal syndrome. World J Nephrol 2015; 4(2): 277-286 [PMID: 25949942 DOI: 10.5527/wjn.v4.i2.277] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
136 Tsien C, Wong F. The impact of acute kidney injury in cirrhosis: does definition matter? Gut 2013;62:1091-2. [PMID: 23426896 DOI: 10.1136/gutjnl-2013-304576] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
137 Best LM, Freeman SC, Sutton AJ, Cooper NJ, Tng EL, Csenar M, Hawkins N, Pavlov CS, Davidson BR, Thorburn D, Cowlin M, Milne EJ, Tsochatzis E, Gurusamy KS. Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis. Cochrane Database Syst Rev. 2019;9:CD013103. [PMID: 31513287 DOI: 10.1002/14651858.cd013103.pub2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
138 Trinh S, Le AK, Chang ET, Hoang J, Jeong D, Chung M, Lee MH, Wang U, Henry L, Cheung R, Nguyen MH. Changes in Renal Function in Patients With Chronic HBV Infection Treated With Tenofovir Disoproxil Fumarate vs Entecavir. Clin Gastroenterol Hepatol. 2019;17:948-956.e1. [PMID: 30130625 DOI: 10.1016/j.cgh.2018.08.037] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
139 Adebayo D, Neong SF, Wong F. Refractory ascites in liver cirrhosis. Am J Gastroenterol. 2018;. [PMID: 29973706 DOI: 10.1038/s41395-018-0185-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
140 Shah N, Mohamed FE, Jover-Cobos M, Macnaughtan J, Davies N, Moreau R, Paradis V, Moore K, Mookerjee R, Jalan R. Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis. Liver Int. 2013;33:398-409. [PMID: 23402610 DOI: 10.1111/liv.12047] [Cited by in Crossref: 65] [Cited by in F6Publishing: 48] [Article Influence: 8.1] [Reference Citation Analysis]
141 Davenport A, Cholongitas E, Xirouchakis E, Burroughs AK. Pitfalls in assessing renal function in patients with cirrhosis--potential inequity for access to treatment of hepatorenal failure and liver transplantation. Nephrol Dial Transplant. 2011;26:2735-2742. [PMID: 21690201 DOI: 10.1093/ndt/gfr354] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
142 Hilmi IA, Damian D, Al-Khafaji A, Planinsic R, Boucek C, Sakai T, Chang CC, Kellum JA. Acute kidney injury following orthotopic liver transplantation: incidence, risk factors, and effects on patient and graft outcomes. Br J Anaesth. 2015;114:919-926. [PMID: 25673576 DOI: 10.1093/bja/aeu556] [Cited by in Crossref: 143] [Cited by in F6Publishing: 119] [Article Influence: 23.8] [Reference Citation Analysis]
143 Bucsics T, Schwabl P, Mandorfer M, Bota S, Sieghart W, Ferlitsch A, Trauner M, Reiberger T, Peck-Radosavljevic M. The trigger matters - outcome of hepatorenal syndrome vs. specifically triggered acute kidney injury in cirrhotic patients with ascites. Liver Int 2016;36:1649-56. [PMID: 27169985 DOI: 10.1111/liv.13160] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
144 Møller S, Bendtsen F. Complications of cirrhosis. A 50 years flashback. Scand J Gastroenterol. 2015;50:763-780. [PMID: 25881709 DOI: 10.3109/00365521.2015.1021709] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
145 Qasem AA, Farag SE, Hamed E, Emara M, Bihery A, Pasha H. Urinary biomarkers of acute kidney injury in patients with liver cirrhosis. ISRN Nephrol. 2014;2014:376795. [PMID: 24967242 DOI: 10.1155/2014/376795] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
146 Heung M, Koyner JL. Entanglement of Sepsis, Chronic Kidney Disease, and Other Comorbidities in Patients Who Develop Acute Kidney Injury. Seminars in Nephrology 2015;35:23-37. [DOI: 10.1016/j.semnephrol.2015.01.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
147 Wong F, Reddy KR, O'Leary JG, Garcia-Tsao G, Kamath PS, Bajaj JS; North American Consortium for the Study of the Liver. Reply. Liver Transpl 2019;25:1586-7. [PMID: 31344749 DOI: 10.1002/lt.25612] [Reference Citation Analysis]
148 Bellomo R, Ronco C, Mehta RL, Asfar P, Boisramé-Helms J, Darmon M, Diehl JL, Duranteau J, Hoste EAJ, Olivier JB, Legrand M, Lerolle N, Malbrain MLNG, Mårtensson J, Oudemans-van Straaten HM, Parienti JJ, Payen D, Perinel S, Peters E, Pickkers P, Rondeau E, Schetz M, Vinsonneau C, Wendon J, Zhang L, Laterre PF. Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference. Ann Intensive Care 2017;7:49. [PMID: 28474317 DOI: 10.1186/s13613-017-0260-y] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 15.0] [Reference Citation Analysis]
149 Tu KH, Jenq CC, Tsai MH, Hsu HH, Chang MY, Tian YC, Hung CC, Fang JT, Yang CW, Chen YC. Outcome scoring systems for short-term prognosis in critically ill cirrhotic patients. Shock. 2011;36:445-450. [PMID: 21841535 DOI: 10.1097/shk.0b013e31822fb7e2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
150 Pham PT, Lunsford KE, Bunnapradist S, Danovitch GM. Simultaneous liver–kidney transplantation or liver transplantation alone for patients in need of liver transplantation with renal dysfunction: . Current Opinion in Organ Transplantation 2016;21:194-200. [DOI: 10.1097/mot.0000000000000299] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 2.2] [Reference Citation Analysis]
151 Allegretti AS, Ortiz G, Wenger J, Deferio JJ, Wibecan J, Kalim S, Tamez H, Chung RT, Karumanchi SA, Thadhani RI. Prognosis of Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis: A Prospective Cohort Study. Int J Nephrol. 2015;2015:108139. [PMID: 26266048 DOI: 10.1155/2015/108139] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
152 Belcher JM, Sanyal AJ, Peixoto AJ, Perazella MA, Lim J, Thiessen-Philbrook H, Ansari N, Coca SG, Garcia-Tsao G, Parikh CR;  TRIBE-AKI Consortium. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology. 2014;60:622-632. [PMID: 24375576 DOI: 10.1002/hep.26980] [Cited by in Crossref: 159] [Cited by in F6Publishing: 134] [Article Influence: 22.7] [Reference Citation Analysis]
153 Low G, Alexander GJ, Lomas DJ. Hepatorenal syndrome: aetiology, diagnosis, and treatment. Gastroenterol Res Pract 2015;2015:207012. [PMID: 25649410 DOI: 10.1155/2015/207012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
154 Seo YS, Park SY, Kim MY, Kim SG, Park JY, Yim HJ, Jang BK, Park SH, Kim JH, Suk KT, Kim JD, Kim TY, Cho EY, Lee JS, Jung SW, Jang JY, An H, Tak WY, Baik SK, Hwang JS, Kim YS, Sohn JH, Um SH. Serum cystatin C level: An excellent predictor of mortality in patients with cirrhotic ascites: Cystatin C in cirrhotic ascites patients. Journal of Gastroenterology and Hepatology 2018;33:910-7. [DOI: 10.1111/jgh.13983] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
155 Gerbes AL. The impact of acute kidney injury in cirrhosis: does definition matter?: Table 1. Gut 2013;62:1091.1-1091. [DOI: 10.1136/gutjnl-2012-304378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
156 Pipili C, Cholongitas E. Renal dysfunction in patients with cirrhosis: Where do we stand? World J Gastrointest Pharmacol Ther 2014; 5(3): 156-168 [PMID: 25133044 DOI: 10.4292/wjgpt.v5.i3.156] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
157 Siddiqui MS, Stravitz RT. Intensive care unit management of patients with liver failure. Clin Liver Dis. 2014;18:957-978. [PMID: 25438294 DOI: 10.1016/j.cld.2014.07.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
158 Jaques DA, Spahr L, Berra G, Poffet V, Lescuyer P, Gerstel E, Garin N, Martin PY, Ponte B. Biomarkers for acute kidney injury in decompensated cirrhosis: A prospective study. Nephrology (Carlton). 2019;24:170-180. [PMID: 29369449 DOI: 10.1111/nep.13226] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
159 Moore K. Acute kidney injury in cirrhosis: a changing spectrum. Hepatology. 2013;57:435-437. [PMID: 22886711 DOI: 10.1002/hep.26003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
160 Wong F, Reddy KR, O’leary JG, Tandon P, Biggins SW, Garcia‐tsao G, Maliakkal BJ, Lai JC, Fallon MB, Vargas HE, Subramanian R, Thuluvath PJ, Kamath PS, Thacker L, Bajaj JS. Impact of Chronic Kidney Disease on Outcomes in Cirrhosis. Liver Transpl 2019;25:870-80. [DOI: 10.1002/lt.25454] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
161 Inoue Y, Soyama A, Takatsuki M, Hidaka M, Kinoshita A, Natsuda K, Baimakhanov Z, Kugiyama T, Adachi T, Kitasato A, Kuroki T, Eguchi S. Does the development of chronic kidney disease and acute kidney injury affect the prognosis after living donor liver transplantation? Clin Transplant 2016;30:518-27. [PMID: 26865166 DOI: 10.1111/ctr.12715] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
162 Angeli P, Ginès P, Wong F, Bernardi M, Boyer TD, Gerbes A, Moreau R, Jalan R, Sarin SK, Piano S, Moore K, Lee SS, Durand F, Salerno F, Caraceni P, Kim WR, Arroyo V, Garcia-tsao G. Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites. Journal of Hepatology 2015;62:968-74. [DOI: 10.1016/j.jhep.2014.12.029] [Cited by in Crossref: 333] [Cited by in F6Publishing: 274] [Article Influence: 55.5] [Reference Citation Analysis]
163 Bozanich NK, Kwo PY. Renal Insufficiency in the Patient with Chronic Liver Disease. Clinics in Liver Disease 2015;19:45-56. [DOI: 10.1016/j.cld.2014.09.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
164 Yuan W, Zhang YY, Zhang ZG, Zou Y, Lu HZ, Qian ZP. Risk Factors and Outcomes of Acute Kidney Injury in Patients With Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Am J Med Sci 2017;353:452-8. [PMID: 28502331 DOI: 10.1016/j.amjms.2017.03.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
165 Yang QJ, Kluger M, Goryński K, Pawliszyn J, Bojko B, Yu A, Noh K, Selzner M, Jerath A, Mccluskey S, Pang KS, Wąsowicz M. Comparing early liver graft function from heart beating and living-donors: A pilot study aiming to identify new biomarkers of liver injury: Liver graft function and novel markers. Biopharm Drug Dispos 2017;38:326-39. [DOI: 10.1002/bdd.2066] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
166 Klein SJ, Lehner GF, Forni LG, Joannidis M. Oliguria in critically ill patients: a narrative review. J Nephrol 2018;31:855-62. [PMID: 30298272 DOI: 10.1007/s40620-018-0539-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
167 Fiacco F, Melandro F, Umbro I, Zavatto A, Cappoli A, Poli E, Ginanni Corradini S, Merli M, Tinti F, Nofroni I, Berloco PB, Rossi M, Mitterhofer AP. Fluctuations of Estimated Glomerular Filtration Rate Outside Kidney Disease Improving Global Outcomes Diagnostic Criteria for Acute Kidney Injury in End-Stage Liver Disease Outpatients and Outcome Postliver Transplantation. Transplant Direct 2018;4:e222. [PMID: 29399624 DOI: 10.1097/TXD.0000000000000733] [Reference Citation Analysis]
168 Huang Z, Lin C, Fang J, Wang N, Zhou R, Pan C. Acute kidney injury in hepatitis B-related acute-on-chronic liver failure without preexisting liver cirrhosis. Hepatol Int 2015;9:416-23. [DOI: 10.1007/s12072-015-9636-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
169 Francoz C, Durand F. Type-1 hepatorenal syndrome in patients with cirrhosis and infection vs. sepsis-induced acute kidney injury: what matters? J Hepatol 2014;60:907-9. [PMID: 24508549 DOI: 10.1016/j.jhep.2014.02.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
170 Maiwall R, Chandel SS, Wani Z, Kumar S, Sarin SK. SIRS at Admission Is a Predictor of AKI Development and Mortality in Hospitalized Patients with Severe Alcoholic Hepatitis. Dig Dis Sci 2016;61:920-9. [PMID: 26470868 DOI: 10.1007/s10620-015-3921-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
171 Sargenti K, Prytz H, Strand A, Nilsson E, Kalaitzakis E. Healthcare-associated and nosocomial bacterial infections in cirrhosis: predictors and impact on outcome. Liver Int. 2015;35:391-400. [PMID: 25039438 DOI: 10.1111/liv.12625] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
172 Choi YJ, Kim JH, Koo JK, Lee CI, Lee JY, Yang JH, Ko SY, Choe WH, Kwon SY, Lee CH. Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal. Clin Mol Hepatol. 2014;20:185-191. [PMID: 25032185 DOI: 10.3350/cmh.2014.20.2.185] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
173 Tandon P, James MT, Abraldes JG, Karvellas CJ, Ye F, Pannu N. Relevance of New Definitions to Incidence and Prognosis of Acute Kidney Injury in Hospitalized Patients with Cirrhosis: A Retrospective Population-Based Cohort Study. PLoS One 2016;11:e0160394. [PMID: 27504876 DOI: 10.1371/journal.pone.0160394] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
174 Tariq R, Hadi Y, Chahal K, Reddy S, Salameh H, Singal AK. Incidence, Mortality and Predictors of Acute Kidney Injury in Patients with Cirrhosis: A Systematic Review and Meta-analysis. J Clin Transl Hepatol. 2020;8:135-142. [PMID: 32832393 DOI: 10.14218/jcth.2019.00060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
175 Adebayo D, Morabito V, Davenport A, Jalan R. Renal dysfunction in cirrhosis is not just a vasomotor nephropathy. Kidney Int. 2015;87:509-515. [PMID: 25296092 DOI: 10.1038/ki.2014.338] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 7.1] [Reference Citation Analysis]
176 Shah AS, Amarapurkar DN. Spectrum of hepatitis B and renal involvement. Liver Int. 2018;38:23-32. [PMID: 28627094 DOI: 10.1111/liv.13498] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
177 Park J, Jeong J, Choi HJ, Shim JW, Lee HM, Hong SH, Park CS, Choi JH, Chae MS. Role of thrombocytopenia in risk stratification for acute kidney injury after living donor liver transplantation. Platelets 2021;32:453-62. [PMID: 32299264 DOI: 10.1080/09537104.2020.1754377] [Reference Citation Analysis]
178 Fagundes C, Ginès P. Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis. Am J Kidney Dis. 2012;59:874-885. [PMID: 22480795 DOI: 10.1053/j.ajkd.2011.12.032] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
179 Fukazawa K, Lee HT. Updates on Hepato-Renal Syndrome. J Anesth Clin Res. 2013;4:352. [PMID: 24459604 DOI: 10.4172/2155-6148.1000352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
180 Tariq R, Singal AK. Management of Hepatorenal Syndrome: A Review. J Clin Transl Hepatol 2020;8:192-9. [PMID: 32832400 DOI: 10.14218/JCTH.2020.00011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
181 Maurel P, Prémaud A, Carrier P, Essig M, Barbier L, Rousseau A, Silvain C, Causse X, Debette-Gratien M, Jacques J, Marquet P, Salamé E, Loustaud-Ratti V. Evaluation of Longitudinal Exposure to Tacrolimus as a Risk Factor of Chronic Kidney Disease Occurrence Within the First-year Post-Liver Transplantation. Transplantation 2021;105:1585-94. [PMID: 32639405 DOI: 10.1097/TP.0000000000003384] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
182 Davenport A. AKI in a patient with cirrhosis and ascites. Clin J Am Soc Nephrol. 2012;7:2041-2048. [PMID: 22977213 DOI: 10.2215/cjn.03390412] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
183 Pan HC, Jenq CC, Tsai MH, Fan PC, Chang CH, Chang MY, Tian YC, Hung CC, Fang JT, Yang CW, Chen YC. Risk models and scoring systems for predicting the prognosis in critically ill cirrhotic patients with acute kidney injury: a prospective validation study. PLoS One. 2012;7:e51094. [PMID: 23236437 DOI: 10.1371/journal.pone.0051094] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
184 Wong F, O'Leary JG, Reddy KR, Patton H, Kamath PS, Fallon MB, Garcia-Tsao G, Subramanian RM, Malik R, Maliakkal B, Thacker LR, Bajaj JS;  North American Consortium for Study of End-Stage Liver Disease. New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology 2013; 145: 1280-8. e1. [PMID: 23999172 DOI: 10.1053/j.gastro.2013.08.051] [Cited by in Crossref: 150] [Cited by in F6Publishing: 133] [Article Influence: 18.8] [Reference Citation Analysis]
185 Juanola A, Solé C, Toapanta D, Ginès P, Solà E. Monitoring Renal Function and Therapy of Hepatorenal Syndrome Patients with Cirrhosis. Clin Liver Dis 2021;25:441-60. [PMID: 33838860 DOI: 10.1016/j.cld.2021.01.011] [Reference Citation Analysis]
186 Wong F, O'Leary JG, Reddy KR, Garcia-Tsao G, Fallon MB, Biggins SW, Subramanian RM, Thuluvath PJ, Kamath PS, Patton H, Maliakkal B, Tandon P, Vargas H, Thacker L, Bajaj JS. Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes. Am J Gastroenterol 2017;112:1103-10. [PMID: 28440305 DOI: 10.1038/ajg.2017.122] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 9.5] [Reference Citation Analysis]
187 Pitlick M, Rastogi P. All That Glitters Yellow Is Not Gold: Presentation and Pathophysiology of Bile Cast Nephropathy. Int J Surg Pathol 2017;25:652-8. [DOI: 10.1177/1066896917713133] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
188 Ahmed QA, El Sayed FS, Emad H, Mohamed E, Ahmed B, Heba P. Urinary biomarkers of acute kidney injury in patients with liver cirrhosis. Med Arch 2014;68:132-6. [PMID: 24937940 DOI: 10.5455/medarh.2014.68.132-136] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
189 Slack AJ, McPhail MJ, Ostermann M, Bruce M, Sherwood R, Musto R, Dew T, Auzinger G, Bernal W, O'Grady J, Heneghan MA, Moore K, Wendon JA. Predicting the development of acute kidney injury in liver cirrhosis--an analysis of glomerular filtration rate, proteinuria and kidney injury biomarkers. Aliment Pharmacol Ther 2013;37:989-97. [PMID: 23577724 DOI: 10.1111/apt.12299] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
190 Verdelho M, Perdigoto R, Machado J, Mateus É, Marcelino P, Pereira R, Fortuna P, Bagulho L, Bento L, Ribeiro F, Nolasco F, Martins A, Barroso E. Acute-on-Chronic Liver Failure: A Portuguese Single-Center Reference Review. GE Port J Gastroenterol 2018;25:18-23. [PMID: 29457046 DOI: 10.1159/000478988] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
191 Mizota T, Minamisawa S, Imanaka Y, Fukuda K. Oliguria without serum creatinine increase after living donor liver transplantation is associated with adverse post-operative outcomes. Acta Anaesthesiol Scand 2016;60:874-81. [DOI: 10.1111/aas.12722] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
192 Pan HC, Chien YS, Jenq CC, Tsai MH, Fan PC, Chang CH, Chang MY, Tian YC, Fang JT, Yang CW, Chen YC. Acute Kidney Injury Classification for Critically Ill Cirrhotic Patients: A Comparison of the KDIGO, AKIN, and RIFLE Classifications. Sci Rep 2016;6:23022. [PMID: 26983372 DOI: 10.1038/srep23022] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
193 Schwaiger E, Simon A, Wabel P, Schairer B, Berner C, Signorini L, Ernstbrunner M, Evstatiev R, Schwabl P, Hinterholzer G, Frommlet F, Vychytil A, Müller CJ, Hecking M. Bioimpedance spectroscopy for fluid status assessment in patients with decompensated liver cirrhosis: Implications for peritoneal dialysis. Sci Rep 2020;10:2869. [PMID: 32071351 DOI: 10.1038/s41598-020-59817-3] [Reference Citation Analysis]
194 Krones E, Pollheimer MJ, Rosenkranz AR, Fickert P. Cholemic nephropathy - Historical notes and novel perspectives. Biochim Biophys Acta Mol Basis Dis 2018;1864:1356-66. [PMID: 28851656 DOI: 10.1016/j.bbadis.2017.08.028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
195 Wong F. Acute kidney injury in liver cirrhosis: new definition and application. Clin Mol Hepatol. 2016;22:415-422. [PMID: 27987536 DOI: 10.3350/cmh.2016.0056] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
196 Hilmi IA, Planinsic RM, Nicolau-Raducu R, Damian D, Al-Khafaji A, Sakai T, Abu-Elmagd K. Isolated small bowel transplantation outcomes and the impact of immunosuppressants: Experience of a single transplant center. World J Transplant 2013; 3(4): 127-133 [PMID: 24392317 DOI: 10.5500/wjt.v3.i4.127] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
197 Mindikoglu AL, Pappas SC. New Developments in Hepatorenal Syndrome. Clin Gastroenterol Hepatol 2018;16:162-177.e1. [PMID: 28602971 DOI: 10.1016/j.cgh.2017.05.041] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
198 Nadim MK, Kellum JA, Davenport A, Wong F, Davis C, Pannu N, Tolwani A, Bellomo R, Genyk YS;  ADQI Workgroup. Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2012;16:R23. [PMID: 22322077 DOI: 10.1186/cc11188] [Cited by in Crossref: 99] [Cited by in F6Publishing: 79] [Article Influence: 11.0] [Reference Citation Analysis]
199 Verna EC, Brown RS, Farrand E, Pichardo EM, Forster CS, Sola-Del Valle DA, Adkins SH, Sise ME, Oliver JA, Radhakrishnan J. Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis. Dig Dis Sci. 2012;57:2362-2370. [PMID: 22562534 DOI: 10.1007/s10620-012-2180-x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 79] [Article Influence: 10.6] [Reference Citation Analysis]
200 Araujo AD, Alvares-da-silva MR. Akin criteria as a predictor of mortality in cirrhotic patients after spontaneous bacterial peritonitis. Annals of Hepatology 2014;13:390-5. [DOI: 10.1016/s1665-2681(19)30870-1] [Cited by in Crossref: 8] [Article Influence: 1.1] [Reference Citation Analysis]
201 Anand AC, Nandi B, Acharya SK, Arora A, Babu S, Batra Y, Chawla YK, Chowdhury A, Chaoudhuri A, Eapen EC, Devarbhavi H, Dhiman RK, Datta Gupta S, Duseja A, Jothimani D, Kapoor D, Kar P, Khuroo MS, Kumar A, Madan K, Mallick B, Maiwall R, Mohan N, Nagral A, Nath P, Panigrahi SC, Pawar A, Philips CA, Prahraj D, Puri P, Rastogi A, Saraswat VA, Saigal S, Shalimar, Shukla A, Singh SP, Verghese T, Wadhawan M; INASL Task-Force on Acute Liver Failure. Indian National Association for the Study of Liver Consensus Statement on Acute Liver Failure (Part-2): Management of Acute Liver Failure. J Clin Exp Hepatol 2020;10:477-517. [PMID: 33029057 DOI: 10.1016/j.jceh.2020.04.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
202 Leung W, Wong F. Hepatorenal syndrome: do the vasoconstrictors work? Gastroenterol Clin North Am 2011;40:581-98. [PMID: 21893275 DOI: 10.1016/j.gtc.2011.06.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
203 Belcher JM, Garcia-Tsao G, Sanyal AJ, Thiessen-Philbrook H, Peixoto AJ, Perazella MA, Ansari N, Lim J, Coca SG, Parikh CR; TRIBE-AKI Consortium. Urinary biomarkers and progression of AKI in patients with cirrhosis. Clin J Am Soc Nephrol 2014;9:1857-67. [PMID: 25183658 DOI: 10.2215/CJN.09430913] [Cited by in Crossref: 54] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
204 Dhanasekaran R, Gonzales P, West J, Subramanian R, Parekh S, Spivey JR, Reshamwala P, Martin LG, Kim HS. Predictors of early mortality post transjugular intrahepatic portosystemic shunts and the role of hepatic venous pressure gradient. Gastrointestinal Intervention 2012;1:63-8. [DOI: 10.1016/j.gii.2012.08.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
205 Kade G, Lubas A, Spaleniak S, Wojtecka A, Leśniak K, Literacki S, Niemczyk S, Dyrla P. Application of the Molecular Adsorbent Recirculating System in Type 1 Hepatorenal Syndrome in the Course of Alcohol-Related Acute on Chronic Liver Failure. Med Sci Monit 2020;26:e923805. [PMID: 32602472 DOI: 10.12659/MSM.923805] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
206 Sargenti K, Prytz H, Nilsson E, Kalaitzakis E. Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure. Scand J Gastroenterol. 2015;50:875-883. [PMID: 25697824 DOI: 10.3109/00365521.2015.1017834] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
207 Schrier RW, Shchekochikhin D, Gines P. Renal failure in cirrhosis: prerenal azotemia, hepatorenal syndrome and acute tubular necrosis. Nephrol Dial Transplant. 2012;27:2625-2628. [PMID: 22492830 DOI: 10.1093/ndt/gfs067] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
208 Jiang QQ, Han MF, Ma K, Chen G, Wan XY, Kilonzo SB, Wu WY, Wang YL, You J, Ning Q. Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis. World J Gastroenterol 2018; 24(21): 2300-2310 [PMID: 29881239 DOI: 10.3748/wjg.v24.i21.2300] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
209 Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012;380:756-766. [PMID: 22617274 DOI: 10.1016/s0140-6736(11)61454-2] [Cited by in Crossref: 769] [Cited by in F6Publishing: 382] [Article Influence: 85.4] [Reference Citation Analysis]
210 Vasudevan A, Ardalan Z, Gow P, Angus P, Testro A. Efficacy of outpatient continuous terlipressin infusions for hepatorenal syndrome. Hepatology 2016;64:316-8. [PMID: 26524479 DOI: 10.1002/hep.28325] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
211 Møller S, Krag A, Bendtsen F. Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes. Liver Int 2014;34:1153-63. [DOI: 10.1111/liv.12549] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
212 Wong F, Reddy KR, Tandon P, O'Leary JG, Garcia-Tsao G, Vargas HE, Lai JC, Biggins SW, Maliakkal B, Fallon M, Subramanian R, Thuluvath P, Kamath PS, Thacker L, Bajaj JS. Progression of Stage 2 and 3 Acute Kidney Injury in Patients With Decompensated Cirrhosis and Ascites. Clin Gastroenterol Hepatol 2021;19:1661-1669.e2. [PMID: 32798707 DOI: 10.1016/j.cgh.2020.08.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
213 Madan K, Mehta A. Management of renal failure and ascites in patients with cirrhosis. Int J Hepatol 2011;2011:790232. [PMID: 21994871 DOI: 10.4061/2011/790232] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
214 Fickert P, Krones E, Pollheimer MJ, Thueringer A, Moustafa T, Silbert D, Halilbasic E, Yang M, Jaeschke H, Stokman G. Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice. Hepatology. 2013;58:2056-2069. [PMID: 23813550 DOI: 10.1002/hep.26599] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 10.8] [Reference Citation Analysis]
215 Hartleb M, Gutkowski K. Kidneys in chronic liver diseases. World J Gastroenterol 2012; 18(24): 3035-3049 [PMID: 22791939 DOI: 10.3748/wjg.v18.i24.3035] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
216 Kamimura H, Watanabe T, Sugano T, Nakajima N, Yokoyama J, Kamimura K, Tsuchiya A, Takamura M, Kawai H, Kato T, Watanabe G, Yamagiwa S, Terai S. A Case of Hepatorenal Syndrome and Abdominal Compartment Syndrome with High Renal Congestion. Am J Case Rep 2017;18:1000-4. [PMID: 28919595 DOI: 10.12659/ajcr.904663] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
217 Burra P, Giannini EG, Caraceni P, Ginanni Corradini S, Rendina M, Volpes R, Toniutto P. Specific issues concerning the management of patients on the waiting list and after liver transplantation. Liver Int 2018;38:1338-62. [PMID: 29637743 DOI: 10.1111/liv.13755] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
218 Molinari M, Fernandez-Carrillo C, Dai D, Dana J, Clemente-Sanchez A, Dharmayan S, Kaltenmeier C, Liu H, Behari J, Rachakonda V, Ganesh S, Hughes C, Tevar A, Al Harakeh H, Emmanuel B, Humar A, Bataller R. Portal vein thrombosis and renal dysfunction: a national comparative study of liver transplant recipients for NAFLD versus alcoholic cirrhosis. Transpl Int 2021;34:1105-22. [PMID: 33780554 DOI: 10.1111/tri.13873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
219 Ginès P, Fernández J, Durand F, Saliba F. Management of critically-ill cirrhotic patients. J Hepatol. 2012;56 Suppl 1:S13-S24. [PMID: 22300462 DOI: 10.1016/s0168-8278(12)60003-8] [Cited by in Crossref: 86] [Cited by in F6Publishing: 27] [Article Influence: 9.6] [Reference Citation Analysis]
220 Parikh CR, Mansour SG. Perspective on Clinical Application of Biomarkers in AKI. J Am Soc Nephrol 2017;28:1677-85. [PMID: 28220028 DOI: 10.1681/ASN.2016101127] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 10.3] [Reference Citation Analysis]
221 Tawfik AK, Helmy A, Yousef M, Abou-Saif S, Kobtan A, Asaad E, Abd-Elsalam S. Copeptin as a novel marker predicting prognosis of liver cirrhosis and its major complications. Hepat Med 2018;10:87-93. [PMID: 30214326 DOI: 10.2147/HMER.S174267] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
222 Kumar R, Priyadarshi RN, Anand U. Chronic renal dysfunction in cirrhosis: A new frontier in hepatology. World J Gastroenterol 2021; 27(11): 990-1005 [PMID: 33776368 DOI: 10.3748/wjg.v27.i11.990] [Reference Citation Analysis]
223 Joannidis M, Klein SJ, John S, Schmitz M, Czock D, Druml W, Jörres A, Kindgen-Milles D, Kielstein JT, Oppert M, Schwenger V, Willam C, Zarbock A. [Prevention of acute kidney injury in critically ill patients : Recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI]. Med Klin Intensivmed Notfmed 2018;113:358-69. [PMID: 29594317 DOI: 10.1007/s00063-018-0413-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]